Fenofibrate and Arixtra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenofibrate (fenofibrate) and Arixtra (fondaparinux sodium). Common drug interactions include confusional state among females and macular oedema among males.

The phase IV clinical study analyzes what interactions people have when they take Fenofibrate and Arixtra. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Arixtra?

Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

31 people who take Fenofibrate and Arixtra together, and have interactions are studied.

Fenofibrate and Arixtra drug interactions.

What are the common drug interactions of Fenofibrate and Arixtra, by gender? *:

female:

Confusional state
Haematoma (collection of blood outside the blood vessels)
Haemoglobin decreased
Abdominal pain upper
Anaemia (lack of blood)
Cerebral haemorrhage (bleeding within the brain)
Muscle haemorrhage (bleeding in muscle)
Oedema peripheral (superficial swelling)
Overdose
Somnolence (a state of near-sleep, a strong desire for sleep)

male:

Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)
Abdominal wall haematoma (abdominal wall blood clotting)
Confusional state
Dizziness
Extradural haematoma (traumatic brain injury-collection of blood in the 'potential' space between the skull and the outer protective)
Fall
Haematoma (collection of blood outside the blood vessels)
Headache (pain in head)
Insomnia (sleeplessness)
Neurological symptom (symptoms of nervous system disease)

What are the common drug interactions of Fenofibrate and Arixtra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Abdominal pain upper
Drug abuse

20-29:

n/a

30-39:

n/a

40-49:

Aphasia (damage to the parts of the brain that control language)
Balance disorder
Cerebral haemorrhage (bleeding within the brain)
Coma (state of unconsciousness lasting more than six hours)
Confusional state
Fall
Haematoma (collection of blood outside the blood vessels)
Headache (pain in head)
Neurological symptom (symptoms of nervous system disease)

50-59:

Cerebral haemorrhage (bleeding within the brain)
Confusional state
Mydriasis (a dilation of the pupil)
Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)

60+:

Haematoma (collection of blood outside the blood vessels)
Anaemia (lack of blood)
Arthralgia (joint pain)
Asthenia (weakness)
Cerebellar haematoma (blood collection in cerebeller)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Dilatation ventricular
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Disturbance in attention
Dysuria (painful or difficult urination)

What are the existing conditions these people have? *

Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 9.68%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 9.68%
Thrombophlebitis Superficial (swelling (inflammation) of a superficial vein caused by a blood clot): 2 people, 6.45%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and Arixtra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously